Home > Healthcare > Medical Services > Diagnostic Services > Healthcare Regulatory Affairs Outsourcing Market

Healthcare Regulatory Affairs Outsourcing Market Size

  • Report ID: GMI8287
  • Published Date: Feb 2024
  • Report Format: PDF

Healthcare Regulatory Affairs Outsourcing Market Size

Healthcare Regulatory Affairs Outsourcing Market size was valued at USD 7.1 billion in 2023 and is estimated to grow at a CAGR of 8.4% between 2024 and 2032. This robust market growth can be attributed to factors such as the growing need to comply with regulatory requirements, increasing regulatory complexity, and surging demand for faster approval processes for breakthrough drugs and devices.

 

Healthcare regulatory affairs outsourcing refers to the practice of delegating regulatory affairs functions, compliance management, and interaction with regulatory authorities to external service providers. Organizations in the pharmaceutical, biotechnology, and medical device industries may outsource these critical tasks to specialized firms to navigate complex regulatory landscapes, ensuring adherence to evolving standards, and facilitating the approval and marketing of healthcare products in compliance with regulatory requirements.

The healthcare industry operates within a dynamic regulatory environment characterized by evolving standards and guidelines. Outsourcing regulatory affairs becomes crucial as it allows companies to navigate the intricate web of regulations effectively. As companies expand their market presence globally, they encounter a multitude of regulatory frameworks. Outsourcing regulatory affairs becomes a strategic necessity, enabling companies to understand and adhere to country-specific regulations. This ensures a smoother market entry, and timely product approvals, and helps in establishing a strong compliance foundation, facilitating successful global expansion initiatives.
 

Moreover, the healthcare industry faces a continual rise in regulatory complexity with intricate guidelines and compliance requirements. Outsourcing regulatory affairs becomes instrumental in navigating this complexity efficiently. External experts specialize in interpreting and implementing complex regulations, ensuring that companies stay compliant and adapt to evolving regulatory landscapes without compromising the quality and safety of their products.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of healthcare regulatory affairs outsourcing reached USD 7.1 billion in 2023 and is set to cross USD 14.8 billion by 2032, attributed to the growing need to comply with regulatory requirements, and surging demand for faster approval processes for breakthrough drugs and devices.

The product registration & clinical trial segment is anticipated to witness a CAGR of 8.5% through 2032, owing to its role in guiding companies through the complexities of gaining regulatory approvals for new medical products.

North America market accounted for USD 2.8 billion revenue in 2023, driven by well-established medical infrastructure and stringent regulatory environment governing healthcare product.

Accell Clinical Research, LLC, Charles River Laboratories, Clinilabs, Inc., Freyr, Genpact, ICON plc, Labcorp Drug Development, PAREXEL International Corporation, ProPharma Group, Proventa International are some of the major industry contenders.

Healthcare Regulatory Affairs Outsourcing Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 307
  • Countries covered: 22
  • Pages: 180
 Download Free Sample